Ernexa Therapeutics Inc. (ERNA) vs NuCana PLC Sponsored ADR (NCNA)

Ernexa Therapeutics Inc. and NuCana PLC Sponsored ADR are both Biotechnology companies. Ernexa Therapeutics Inc. and NuCana PLC Sponsored ADR are of similar size ($5.9M and $5.7M). Across the 10 metrics below, Ernexa Therapeutics Inc. leads on 5 and NuCana PLC Sponsored ADR on 5.

Valuation

Metric ERNA NCNA Biotechnology median
P/E n/m n/m 7.88
P/S 7.01 n/m 11.47
P/B 1.28 0.00 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 1.45 0.74
EV/Sales 55.39 n/m 10.73
Earnings yield (415.94%) (175,037.66%) (28.84%)
Free cash flow yield (217.53%) (131,687.13%) (23.03%)

Profitability

Metric ERNA NCNA Biotechnology median
Gross margin 83.51% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (321.22%) (68.70%) (57.72%)
Return on assets (176.62%) (45.24%) (49.22%)
Return on invested capital 0.00% (1,130.23%) 0.00%

Growth

Metric ERNA NCNA Biotechnology median
Revenue growth (TTM) (78.60%) — 5.64%
EPS growth (last fiscal year) 95.42% 98.96% —
Revenue growth, 5-year CAGR (50.61%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ERNA NCNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.01 4.73 4.73
Net debt to EBITDA 0.21 1.23 0.96

Dividend

Metric ERNA NCNA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ERNA NCNA Biotechnology median
Market cap 5.91m 5.69m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack